Article (Scientific journals)
The lipid transfer protein STARD7 controls intestinal tumor development in a context-dependent manner.
Shostak, Kateryna; Chen, Yu; Maurizy, Chloé et al.
2026In EMBO Molecular Medicine
Peer Reviewed verified by ORBi
 

Files


Full Text
Published PDF STARD7 in intestinal cancers.pdf
Author postprint (10.35 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Inflammation-driven Intestinal Cancers; STARD7; Wnt-driven Tumor Initiation; mTORC1
Abstract :
[en] The role of phosphatidylcholine transporters such as Stard7 in intestinal cancer development is unknown. To explore this issue, we generated a mouse model lacking Stard7 in intestinal epithelial cells (IECs). Loss of Stard7 impaired mitochondrial Complex I activity, led to a severe metabolic and lipid reprogramming, enhanced mitochondrial ROS production and potentiated an mTORC1/ATF4 signature. As a result, levels of enzymes involved in serine biosynthesis were enhanced in Stard7-deficient IECs. We next assessed the consequences of Stard7 deficiency in both Wnt-dependent tumor initiation and in inflammation-driven tumor development. Strikingly, despite generating similar molecular signatures, Stard7 deficiency inhibited tumor development in Azoxymethane (AOM)/Dextran Sulfate Sodium (DSS)-treated mice but promoted Wnt-driven cancer initiation in the intestine. Apc+/Min mice lacking Stard7 in IECs developed more tumors in the distal colon as well as a specific microbiota signature. Collectively, our results suggest that the genetic status critically controls the effects of Stard7 deficiency on intestinal tumor development.
Disciplines :
Oncology
Author, co-author :
Shostak, Kateryna ;  Université de Liège - ULiège > Département de pharmacie > Chimie médicale
Chen, Yu ;  Université de Liège - ULiège > Département de pharmacie
Maurizy, Chloé  ;  Université de Liège - ULiège > Département de pharmacie > Chimie médicale
Rademaker, Gilles  ;  Université de Liège - ULiège > GIGA > GIGA Cancer - Metastases Research Laboratory
Xu, Xinyi;  Laboratory of Cancer Biology, GIGA Cancer, University of Liege, Sart-Tilman, Liège, Belgium
Blomme, Arnaud  ;  Université de Liège - ULiège > Département de pharmacie
Close, Pierre  ;  Université de Liège - ULiège > Département de pharmacie ; WELBIO-Walloon Excellence in Life Sciences and Biotechnology, WEL Research Institute, WELBIO Department, Wavre, Belgium
Renson, Olivier ;  GIGA Genomics Platform, University of Liege, Liege, Belgium
Van Hul, Matthias;  Metabolism and Nutrition Research group, Louvain Drug Research Institute (LDRI) and Institute of Experimental and Clinical Research (IREC), UCLouvain, Université catholique de Louvain, Brussels, Belgium
Cani, Patrice D ;  WELBIO-Walloon Excellence in Life Sciences and Biotechnology, WEL Research Institute, WELBIO Department, Wavre, Belgium ; Metabolism and Nutrition Research group, Louvain Drug Research Institute (LDRI) and Institute of Experimental and Clinical Research (IREC), UCLouvain, Université catholique de Louvain, Brussels, Belgium ; Section of Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom
Klein, Sebastian;  Institute for Pathology-University Hospital of Cologne, Cologne, Germany ; Department of Hematology and Stem Cell Transplantation, University Duisburg-Essen, University Hospital Essen, Essen, Germany
Florin, Alexandra;  Institute for Pathology-University Hospital of Cologne, Cologne, Germany
Büttner, Reinhard ;  Institute for Pathology-University Hospital of Cologne, Cologne, Germany
Cataldo, Didier  ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie générales, humaines et pathologiques
Delvenne, Philippe ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Nemazanyy, Ivan ;  Platform for Metabolic Analyses, Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS 3633, Paris, France
WATHIEU, Caroline  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service d'oncologie médicale
Hego, Alexandre  ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques
Ormenese, Sandra ;  Université de Liège - ULiège > GIGA > GIGA Platforms - Imaging & Flow cytometry
Peulen, Olivier  ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques
Thiry, Marc  ;  Université de Liège - ULiège > Département des sciences de la vie > Service collectif des enseignements de biologie en bachelier
Krishnankutty, Roopesh ;  Institute of Genetics and Cancer, Edinburgh Cancer Research, Edinburgh, Scotland
Marques, Jair;  Institute of Genetics and Cancer, Edinburgh Cancer Research, Edinburgh, Scotland
von Kriegsheim, Alex;  Institute of Genetics and Cancer, Edinburgh Cancer Research, Edinburgh, Scotland
Chariot, Alain  ;  Université de Liège - ULiège > Département de pharmacie > Chimie médicale
More authors (15 more) Less
Language :
English
Title :
The lipid transfer protein STARD7 controls intestinal tumor development in a context-dependent manner.
Publication date :
30 March 2026
Journal title :
EMBO Molecular Medicine
ISSN :
1757-4676
eISSN :
1757-4684
Publisher :
Springer Science and Business Media LLC, Germany
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
WELBIO - Walloon Excellence in Life Sciences and Biotechnology
Belgian Foundation against Cancer
ULiège - University of Liège
EOS - The Excellence Of Science Program
F.R.S.-FNRS - Fonds de la Recherche Scientifique
UCL - Catholic University of Louvain
Available on ORBi :
since 03 May 2026

Statistics


Number of views
8 (1 by ULiège)
Number of downloads
5 (0 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenCitations
 
0
OpenAlex citations
 
0

Bibliography


Similar publications



Contact ORBi